![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 45, 42802-42807, November 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
From the
Departamento de Bioquímica,
Instituto de Química, Universidade de São Paulo,
São Paulo, SP, 05508-900, Brazil, the ¶ Departamento de
Patologia Clínica, Faculdade de Ciências Médicas,
Universidade Estadual de Campinas, Campinas, SP, 13083-970, Brazil, and
the 
Department of Anesthesiology,
University of Maryland School of Medicine, Baltimore, Maryland
21201
Received for publication, July 31, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Overexpression of the antiapoptotic Bcl-2 protein
enhances the uptake of fluorimetric dyes sensitive to mitochondrial
membrane potential, suggesting that Bcl-2 changes the mitochondrial
proton gradient. In this study, we performed calibrated measurements of
mitochondrial respiration, membrane potential, The Bcl-2 protein, originally described in lymphoma cells (1) and
then found to be widely distributed in a variety of cancerous tissues
(2, 3), is a potent inhibitor of cell death, both programmed and
accidental (4, 5). Bcl-2 is located in biological membranes, including
mitochondria (6, 7), and acts to inhibit mitochondrially
controlled steps leading to cell death. The effects of Bcl-2 on
mitochondrial control of cell death are variable according to the
experimental conditions studied, indicating a multifunctional role for
this protein. For example, Bcl-2 inhibits mitochondrial permeability
transition (8-10), a process often associated with mitochondrial
cytochrome c release and subsequent cell death (8, 11), and
Bcl-2 is also capable of inhibiting cytochrome c release pathways independent of mitochondrial permeability transition, such as
Bid- and Bax-mediated cytochrome c release (12, 13).
Bcl-2 effects on mitochondria determined to date involve almost
exclusively studies conducted under conditions leading to cell death.
Although these studies are essential to understand the antiapoptotic
effects of this protein, it is important to determine whether Bcl-2 can
affect mitochondrial function under basal conditions. Understanding the
changes promoted by Bcl-2 on mitochondrial function in healthy cells
may determine how these cells respond to potentially deadly stimuli and
uncover the common roots of the distinct antiapoptotic effects of
this protein. Furthermore, Bcl-2 may have an unknown role in the
regulation of basal mitochondrial energy metabolism. In fact, some
previous data from both our group and others (9, 10) suggest that Bcl-2
may regulate mitochondrial proton transport across the inner membrane
resulting in higher mitochondrial membrane potentials since
Bcl-2-overexpressing mitochondria take up larger quantities of
membrane potential-sensitive dyes. This increased mitochondrial
membrane potential could explain other Bcl-2 effects such as increased
H2O2 generation (14-16) since mitochondrial
reactive oxygen species generation is strongly inhibited at lower
membrane potentials (17). Unfortunately, the cause of these
mitochondrial changes promoted by Bcl-2 has never been carefully
studied, and these results are often obtained from a single transfected
cell line, raising the possibility that these are not universal Bcl-2
effects. In this study, we investigated the effects of Bcl-2 on
mitochondrial function and structure using two separate cell lines and
found that overexpression of this protein does not affect the membrane
potential, respiration, Cell Cultures--
PC12 pheochromocytoma and immortalized
hypothalamic GT1-7 neuronal cell lines transfected with the human
bcl-2 gene (Bcl-2+) or with a control retroviral construct
(Bcl-2 Mitochondrial Membrane Potential ( Intramitochondrial pH--
Cells (10 mg/ml) were suspended in
medium containing 10 µM BCECF-AM, 250 mM
sucrose, 5 mM pyruvate, 5 mM malate, 5 mM glutamate, 100 µM EGTA, 1 mg/ml bovine
serum albumin, 0.001% or 0.004% digitonin (GT1-7 and PC12
cells, respectively), and 10 mM Hepes, pH 7.2 (KOH) and
incubated at 25 °C for 20 min. The permeabilized cells with
BCECF-loaded mitochondria were then diluted to 2 mg/ml in 4 °C
buffer devoid of BCECF, centrifuged, and resuspended in the same
medium. BCECF fluorescence emission was measured at 550 nm with
variable excitation wavelengths. Intramitochondrial pH was calculated
from the ratio between fluorescence levels at 509 and 450 nm as
described by Molecular Probes and Jung et al. (20, 21). Cells were treated with CCCP and nigericin (1 µM),
and the extracellular medium pH (measured using a standard pH meter) was manipulated between 7 and 8 by adding HCl and KOH. A plot relating
the measured pH to the 509/450 nm fluorescence ratio was used to
determine intramitochondrial pH in the absence of ionophores. All
experiments were conducted within 30 min of mitochondrial loading with
BCECF.
Intramitochondrial [K+]--
Cells (10 mg/ml) were
suspended in medium containing 20 µM PBFI-AM (a
K+ indicator marketed by Molecular Probes) and treated in
the same manner as those loaded with BCECF. PBFI fluorescence emission was measured at 500 nm with variable excitation wavelengths.
Intramitochondrial [K+] was calculated from the ration
between fluorescence levels at 320 and 360 nm as described by Molecular
Probes and Jung et al. (20, 21). Cells were treated with
CCCP and nigericin (1 µM), and spectra were collected in
the presence of varying medium [K+] (50-200
mM). A plot relating [K+] to the fluorescence
ratio was used to determine intramitochondrial [K+] in
the absence of ionophores.
Mitochondrial Isolation--
Mitochondria were isolated from
digitonin-permeabilized GT1-7 and PC12 cells exactly as described by
Moreadith and Fiskum (22) in isolation buffer containing 210 mM mannitol, 75 mM sucrose, 1 mg/ml bovine
serum albumin, 5 mM Hepes, and 1 mM EGTA, pH
7.2 (KOH).
Mitochondrial Particle Sizing and Light Scattering--
Isolated
mitochondria (~0.2 mg/ml) were incubated in 250 mM
sucrose, 10 mM Hepes, 100 µM EGTA, pH 7.2 (KOH), containing 1 µM rotenone and 5 mM
K+ succinate. The suspension was analyzed by a Becton
Dickinson FACSCalibur flow cytometer, and detected with a 488 nm laser. Particle size (forward scattering (FSC)) and light scattering (side
scattering (SSC)) characteristics were analyzed using CellQuest software.
Reagents--
BCECF-AM and PBFI-AM were purchased from Molecular
Probes. Safranin O, EGTA, digitonin, malate, glutamate, pyruvate,
bovine serum albumin, CCCP, nigericin, and valinomycin were from Sigma.
Data Analysis--
Data presented as traces are representative
of at least three similar repetitions. Averages represented in bar
graphs were calculated from data collected in at least three
repetitions using different cell preparations. Error bars indicate
standard errors (S.E.), and significant differences were calculated
using pairwise Tukey tests conducted by SigmaStat®.
Previous studies have shown that Bcl-2 overexpression causes an
increase in the uptake of fluorescent dyes sensitive to the mitochondrial
pH, and
intramitochondrial [K+] in digitonin-permeabilized
PC12 and GT1-7 neural cells that either do not express human Bcl-2
(control transfectants) or that were transfected with and overexpressed
the human bcl-2 gene to evaluate whether Bcl-2
alters mitochondrial inner membrane ion transport. We found that
although Bcl-2-overexpressing cells exhibit higher fluorescence
responses to membrane potential, pH, and K+-sensitive dyes,
this increased response is due to an enhanced accumulation of these
dyes and not an increased mitochondrial membrane potential,
pH, or
[K+]. This result is supported by the presence of equal
respiratory rates in Bcl-2+ and Bcl-2
cells. Possible structural
alterations in Bcl-2+ mitochondria that could account for increases in
fluorescent dye uptake were evaluated using flow cytometry particle
sizing and light scattering determinations. These experiments
established that Bcl-2-overexpressing mitochondria present both
increased volume and structural complexity. We suggest that increased
mitochondrial volume and structural complexity in Bcl-2+ cells may be
related to many of the effects of this protein involved in the
prevention of cell death.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
pH, or intramitochondrial
[K+] but does increase mitochondrial volume and
structural complexity. This increase in volume and structural
complexity explains changes in fluorimetric membrane potential
determinations conducted previously. Based on our results, we propose a
model in which enhanced mitochondrial volume and structural complexity
mediate many of the Bcl-2 effects related to the prevention of cell death.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) were maintained as described previously (4). Prior to the
experiments the cells were trypsinized and suspended in growth
medium supplemented with 10 mM Hepes, pH 7.0. Suspended cells were kept at room temperature for up to 5 h. Cell
viability, as assessed by a cell count in trypan blue, was above 95%
even after 5 h at room temperature. The suspended cells were
centrifuged and resuspended in the medium used in the experiment just
prior to each determination. Cell protein content was determined using
the Biuret method. All experiments were conducted at 37 °C.

)--
Mitochondrial

1 was estimated through
fluorescence changes of safranin O (5 mM) at excitation and
emission wavelengths of 485 and 586 nm, respectively (10, 18). Data
were calibrated using a K+ gradient as described by Akerman
and Wikstrom (19), and the membrane potential obtained for each
K+ concentration was determined using the Nernst
equation assuming intramitochondrial [K+] to be 150 mM, a value quite close to the experimentally determined [K+] in GT1-7 cells (see Fig. 3). A calibration curve was
constructed and fitted using Origin® software, and
all subsequent fluorescence traces were transformed into 
using
the same fitting equation.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

, a result interpreted as an increase in 
induced by this protein (9, 10). This 
effect could explain many changes observed in Bcl-2-overexpressing mitochondria, including increased reactive oxygen species generation (14-16), enhanced Ca2+ uptake capacity, and larger quantities of reduced
pyridine nucleotides (10, 14, 23). To understand the mechanism through
which Bcl-2 apparently enhances 
, we performed measurements of
mitochondrial uptake of the 
-sensitive probe safranin O and
calibrated the data by using K+ gradients and applying the
Nernst equation (see "Experimental Procedures" and Ref. 19). These
experiments were conducted using cultured cells in which low digitonin
concentrations were added to selectively permeabilize the plasma
membrane, promoting a large dilution of cytosolic components while
maintaining cell architecture and mitochondrial function unaltered
(18). This is the preferred method to study the effects of Bcl-2 in
mitochondria from transfected cell lines since mitochondrial isolation
may promote damage to the organelle in a Bcl-2-inhibited manner (18).
As noted previously (9, 10), PC12 pheochromocytoma cells overexpressing
human Bcl-2 (Bcl-2+ cells) decrease safranin fluorescence more
intensely than control transfectant cells (Bcl-2-) and present an
enhanced difference in fluorescence in the presence and absence of the proton ionophore CCCP (
Fluorescence) when respiring on NADH-linked substrates (Fig. 1, upper and
lower left), an effect compatible with a higher 
. A
similar increase in safranin
Fluorescence was observed in a
second transfected cell line (GT1-7 hypothalamic tumor cells; Fig. 1,
lower left). However, when we calibrated 
using a
K+ distribution curve (Fig. 1, upper panels, see
"Experimental Procedures" and Ref. 19), we found that Bcl-2+
mitochondria presented larger safranin responses to equal 
changes (more change in fluorescence with equal K+
additions). By using the best fittings for the fluorescence
versus 
plots (Fig. 1, upper right), we
were able to estimate Bcl-2
and Bcl-2+ 
in the absence of added
K+ and found these to be equal in both cell lines studied
(Fig. 1, lower left). Thus, Bcl-2 increases safranin
fluorescence changes dependent on 
, but this effect seems to be
related to an altered calibration curve and not enhanced 
.

View larger version (31K):
[in a new window]
Fig. 1.
Bcl-2 overexpression increases safranin
quenching but not mitochondrial

. In the top panels,
10 mg/ml PC12 cells were incubated in 250 mM sucrose, 5 mM pyruvate, 5 mM malate, 5 mM
glutamate, 100 µM EGTA, 1 mg/ml bovine serum albumin,
0.004% digitonin, 5 µM safranin O, 1 µg/ml
valinomycin, and 10 mM Hepes, pH 7.2 (NaOH), and safranin
fluorescence was measured as described under "Experimental
Procedures" in the presence of increasing concentrations of
K+ (0.15, 0.3, 0.45, 0.75, 1.05, 1.35, and 1.95 mM) and 5 µM CCCP, added where indicated. The
respective 
for each K+ concentration was calculated
using the Nernst equation (see "Experimental Procedures"), and the
best fitting for the fluorescence versus 
plot
(upper right) was used to estimate 
in the absence of
added K+ for both PC12 and GT1-7 cells incubated under
similar conditions (lower left).
Fluorescence represents
fluorescence readings in the presence of CCCP minus readings without
added K+. In the lower right panel, PC12
respiratory rates and 
(estimated through calibrated safranin
fluorescence changes) were measured in parallel and plotted against
each other under conditions similar to those described above in which
K+ (0.15-1.95 mM) and CCCP (0.1-5
µM) concentrations were varied. *, p < 0.05 when compared with Bcl-2
cells. A.U., arbitrary
units.
We also determined mitochondrial respiratory rates in Bcl-2+ and
Bcl-2
cells (Fig. 1, lower right) and plotted them against the measured membrane potential in the presence of increasing K+ and CCCP concentrations. A change in the linear

/respiration plot would be indicative of altered proton
pumping/oxygen consumption ratios at the mitochondrial respiratory
chain as proposed previously to explain the apparent higher 
in
Bcl-2+ mitochondria (9). We found that Bcl-2 does not change the
correlation between mitochondrial oxygen consumption and H+
pumping, a result which supports the finding that mitochondrial 
is equal in Bcl-2+ and Bcl-2
cells.
Safranin is a lipophilic cation that accumulates within or in near
proximity to the mitochondrial inner membrane, reducing the
fluorescence of the suspension in a manner proportional to the negative
charge of the mitochondrial matrix (19). Thus, safranin fluorescence
traces measure only changes in charge across the inner membrane and are
insensitive to a second component of the mitochondrial H+
gradient,
pH. In addition, the estimated 
calculated using the
Nernst equation in Fig. 1 assumes intramitochondrial K+
concentrations to be ~150 mM and equal in Bcl-2+ and
Bcl-2
cells. To ascertain that Bcl-2 affects safranin distribution
and not the mitochondrial proton gradient, we measured both
pH and
K+ concentrations in Bcl-2+ and Bcl-2
mitochondria.
The experiments shown in Fig. 2 compare
pH levels in Bcl-2
and Bcl-2+ mitochondria. We found that the
addition of nigericin, a K+/H+ exchanger that
reduces
pH and increases 
, promotes very similar effects on

measured by calibrated safranin fluorescence in Bcl-2
and
Bcl-2+ mitochondria (Fig. 2, upper panels). To confirm that
Bcl-2 did not affect
pH, we loaded GT1-7 mitochondria with the
esterified form of the pH-sensitive dye BCECF. PC12 mitochondria were
not used in this experiment since they loaded very poorly with this
dye, and the final fluorescence levels were insufficient to accurately
estimate
pH. In GT1-7 Bcl-2+ cells, BCECF fluorescence was more
intense and responded more significantly to the addition of nigericin
than that in Bcl-2
cells (Fig. 2, bottom left). However,
by calibrating the fluorescence traces (see "Experimental Procedures"), we found no difference in intramitochondrial pH levels
in Bcl-2
and Bcl-2+ mitochondria despite a consistently higher BCECF
load (Fig. 2, bottom right). These results indicated that,
although GT1-7 mitochondria are more intensely loaded with BCECF, there
is no difference in
pH between Bcl-2
and Bcl-2+ mitochondria.
|
Intramitochondrial K+ levels were determined in Fig.
3 by loading mitochondria with the
K+ probe PBFI-AM. Again PC12 cells loaded very poorly with
the dye, so only GT1-7 cells were used. We found that, although Bcl-2+ mitochondria loaded more dye and presented more intense fluorescence (Fig. 3, upper panels and lower right), no
difference in intramitochondrial K+ concentrations could be
detected when the data were calibrated (lower left). Indeed,
intramitochondrial K+ concentrations determined using PBFI
were quite close to the estimated K+ concentrations used to
calibrate 
determinations in Figs. 1 and 2, ensuring the accuracy
of our 
estimation.
|
In the absence of any difference in 
,
pH, or
intramitochondrial [K+], the increased fluorescence
response to three different dyes observed in the Bcl-2+ mitochondria
suggests the presence of a larger mitochondrial membrane surface (to
increase safranin distribution since safranin accumulates in close
contact to or within the inner membrane, Ref. 19) and matrix volume (to
increase intramitochondrial BCECF and PBFI accumulation). To
investigate this surprising possibility, we isolated mitochondria from
GT1-7 and PC12 Bcl-2
and Bcl-2+ cells and evaluated their size and
structural complexity using flow cytometry (Fig.
4).
|
FSC measurements using a flow cytometer can be used to estimate
particle size since the intensity of light scattered at small angles
from an incident laser beam is proportional to particle volume as
demonstrated by Mullaney et al. (24). In the top
panels of Fig. 4, we compared FSC in Bcl-2
and Bcl-2+
mitochondria isolated from GT1-7 cells. We found that Bcl-2+
mitochondria present two populations of distinct sizes and that the
average particle size of these mitochondria is larger than Bcl-2
mitochondria (Fig. 4, top left). In addition, flow cytometry
can determine mitochondrial structural complexity as measured by
particle light scattering (SSC), which is dependent on the refractive
index of each particle. Side scattering measurements show that GT1-7
Bcl-2+ mitochondria present increased structural complexity in relation
to Bcl-2
mitochondria (Fig. 4, top right). In PC12 cells,
mitochondrial volume and complexity increases in Bcl-2+ cells were less
pronounced but still evident (Fig. 4, lower panels). The
increase in both mitochondrial size and complexity, as determined by
increases in forward and side scattering, excludes the possibility that the difference between Bcl-2+ and Bcl-2
mitochondria is due to membrane damage promoted by mitochondrial isolation since mitochondria with more permeable membranes present increased size and decreased light scattering (25). Thus, in two distinct cell lines, Bcl-2 overexpression enhanced the mean size and complexity of mitochondria. The enhanced size and structural complexity of Bcl-2+ mitochondria explain why these organelles present larger responses to fluorescent dyes without changes in the mitochondrial function these dyes measure.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we examined the effects of Bcl-2 overexpression on
mitochondrial energetics and structure using two unrelated bcl-2-transfected cell lines. We found that Bcl-2+
mitochondria, previously thought to present higher 
due to
increased uptake of membrane potential probes such as safranin and
rhodamine 123 (9, 10), do not show any difference in 
when this
measurement is calibrated using K+ gradients (Fig. 1).
Instead Bcl-2+ mitochondria present a larger ability to promote
fluorescence changes not only of the membrane potential probe safranin
but also of pH- and K+-sensitive probes BCECF and PBFI
(Figs. 2 and 3) without apparent changes in 
,
pH, or
intramitochondrial [K+]. This finding indicates that
studies comparing non-calibrated fluorescence responses in cell
lines with different Bcl-2 expression levels may, in fact, misinterpret
fluorescence signals and should be carefully reevaluated.
Previous studies involving isolated mitochondria suggest that the
increase in response promoted by Bcl-2 in fluorescence 
measurements is not due to a larger number of mitochondria in Bcl-2-overexpressing cells (26), a result supported by the fact that no
difference in respiratory activity can be measured between Bcl-2+ and
Bcl-2
cells (Fig. 1, lower left). This observation suggests that Bcl-2+ mitochondria present both a more extensive membrane surface, interacting more intensely with membrane-accumulated probes such as safranin, and larger matrix volumes to enhance the
accumulation of intramitochondrial probes such as BCECF and PBFI. These
differences in mitochondrial volume and membrane content were confirmed
by using a flow cytometer to measure particle size (forward scattering)
and structural complexity (side scattering) of isolated Bcl-2+ and
Bcl-2
mitochondria (Fig. 4). The exact nature of the structural
changes present in Bcl-2+ mitochondria is still not clear and will have
to be investigated using three-dimensional imaging techniques since
conventional electron microscopy does not show any striking differences
between Bcl-2
and Bcl-2+ mitochondrial morphology (10).
Independently of the exact nature of the structural alterations
promoted by Bcl-2, our data using both fluorescent dyes and light
scattering of individual mitochondria through flow cytometry clearly
indicate that Bcl-2+ mitochondria are larger. The presence of larger
mitochondria and, most probably, larger matrix volumes may explain why
Bcl-2-overexpressing mitochondria have been previously found to present
a larger capacity to accumulate Ca2+ ions (Ref. 26, and see
the scheme in Fig. 5) independently of
their increased resistance to undergo non-selective inner membrane permeabilization following excessive Ca2+ uptake
(mitochondrial permeability transition, Refs. 10 and 11). It is also
possible that the increased structural complexity of Bcl-2+
mitochondria is related to changes in membrane structure such as
increases in cristal folds, resulting in resistance to cytochrome c loss under conditions in which the outer
membrane is permeabilized (27). Cytochrome c normally
interacts closely with the inner membrane and must be displaced to the
intermembrane space to be released into the cytosol (28). Finally,
larger matrix volumes may explain why Bcl-2+ cells present higher
quantities of matrix-soluble components such as NADPH, NADH, and
glutathione (10, 14, 23). The antioxidant effects of NADPH and GSH are related to the increased resistance Bcl-2+ cells present to oxidative damage (10, 14, 16, 23).
|
In summary, we found that Bcl-2 does not affect mitochondrial 
,
pH, or intramitochondrial K+ concentrations but alters
mitochondrial structure, resulting in increased size and complexity.
These changes are accompanied by an enhancement in the response to
fluorescent dyes, including those that measure mitochondrial 
.
Enhanced volume and structural complexity may affect the response
presented by Bcl-2+ cells to normally deadly stimuli, inhibiting
apoptosis and necrosis by preventing cytochrome c
release, increasing Ca2+ uptake capacity, and enhancing
antioxidant defenses (see Fig. 5 for a proposed model).
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge Edson Alves Gomes for excellent technical assistance and Prof. A. E. Vercesi for stimulating discussions and for allowing ready access to the flow cytometer. Dr. A. Starkov and Prof. E. J. Bechara are thanked for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This project was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Grant 00/09642-5 and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Produtividade em Pesquisa Grant 300843/00-3.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Fax: 55-11-3815-5579; E-mail: alicia@iq.usp.br.
Supported by a Coordenação de
Aperfeiçoamento de Pessoal de Nível Superior (CAPES) scholarship.
** Supported by a FAPESP scholarship.
Published, JBC Papers in Press, August 30, 2002, DOI 10.1074/jbc.M207765200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:

, membrane
potential;
AM, acetoxymethyl ester;
BCECF, 2',7'-bis(2-carboxyethyl)-5(and -6)-carboxyfluorescein;
CCCP, carbonyl
cyanide m-chlorophenylhydrazone;
FSC, forward scattering;
SSC, side scattering.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Tsujimoto, Y., Ikegaki, N., and Croce, C. M. (1987) Oncogene 2, 3-7[Medline] [Order article via Infotrieve] |
| 2. | Reed, J. C. (1995) Curr. Opin. Oncol. 7, 541-546[Medline] [Order article via Infotrieve] |
| 3. | Adams, J. M., and Cory, S. (2001) Trends Biochem. Sci. 26, 61-66[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Kane, D. J.,
Sarafian, T. A.,
Anton, R.,
Hahn, H.,
Gralla, E. B.,
Valentine, J. S.,
Ord, T.,
and Bredesen, D. E.
(1993)
Science
262,
1274-1277 |
| 5. | Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998) Annu. Rev. Physiol. 60, 619-642[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Monaghan, P., Robertson, D., Amos, T. A., Dyer, M. J., Mason, D. Y., and Greaves, M. F. (1992) J. Histochem. Cytochem. 40, 1819-1825[Abstract] |
| 7. |
Krajewski, S.,
Tanaka, S.,
Takayama, S.,
Schibler, M. J.,
Fenton, W.,
and Reed, J. C.
(1993)
Cancer Res.
53,
4701-4714 |
| 8. |
Zamzami, N.,
Susin, S. A.,
Marchetti, P.,
Hirsch, T.,
Gomez-Monterrey, I.,
Castedo, M.,
and Kroemer, G.
(1996)
J. Exp. Med.
183,
1533-1544 |
| 9. |
Shimizu, S.,
Eguchi, Y.,
Kamiike, W.,
Funahashi, Y.,
Mignon, A.,
Lacronique, V.,
Matsuda, H.,
and Tsujimoto, Y.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1455-1459 |
| 10. | Kowaltowski, A. J., Vercesi, A. E., and Fiskum, G. (2000) Cell Death Differ. 7, 903-910[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Kowaltowski, A. J., Castilho, R. F., and Vercesi, A. E. (2001) FEBS Lett. 495, 12-15[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Polster, B. M.,
Kinnally, K. W.,
and Fiskum, G.
(2001)
J. Biol. Chem.
276,
37887-37894 |
| 13. |
Jurgensmeier, J. M.,
Xie, Z.,
Deveraux, Q.,
Ellerby, L.,
Bredesen, D.,
and Reed, J. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4997-5002 |
| 14. |
Esposti, M. D.,
Hatzinisiriou, I.,
McLennan, H.,
and Ralph, S.
(1999)
J. Biol. Chem.
274,
29831-29837 |
| 15. |
Steinman, H. M.
(1995)
J. Biol. Chem.
270,
3487-3490 |
| 16. |
Armstrong, J. S.,
and Jones, D. P.
(2002)
FASEB J.
16,
1263-1265 |
| 17. | Korshunov, S. S., Skulachev, V. P., and Starkov, A. A. (1997) FEBS Lett. 416, 15-18[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Fiskum, G., Kowaltowski, A. J., Andreyev, A. Y., Kushnareva, Y. E., and Starkov, A. A. (2000) Methods Enzymol. 322, 222-234[Medline] [Order article via Infotrieve] |
| 19. | Akerman, K. E., and Wikstrom, M. K. (1976) FEBS Lett. 68, 191-197[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Jung, D. W., Apel, L., and Brierley, G. P. (1990) Biochemistry 29, 4121-4128[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Jung, D. W.,
Baysal, K.,
and Brierley, G. P.
(1995)
J. Biol. Chem.
270,
672-678 |
| 22. | Moreadith, R. W., and Fiskum, G. (1984) Anal. Biochem. 137, 360-367[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Ellerby, L. M., Ellerby, H. M., Park, S. M., Holleran, A. L., Murphy, A. N., Fiskum, G., Kane, D. J., Testa, M. P., Kayalar, C., and Bredesen, D. E. (1996) J. Neurochem. 67, 1259-1267[Medline] [Order article via Infotrieve] |
| 24. | Mullaney, P. F., Van Dilla, M. A., Coulter, J. R., and Dean, P. N. (1969) Rev. Sci. Instrum. 40, 1029-1032[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Garlid, K. D.,
and Beavis, A. D.
(1985)
J. Biol. Chem.
260,
13434-13441 |
| 26. |
Murphy, A. N.,
Bredesen, D. E.,
Cortopassi, G.,
Wang, E.,
and Fiskum, G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9893-9898 |
| 27. |
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312 |
| 28. |
Ott, M.,
Robertson, J. D.,
Gogvadze, V.,
Zhivotovsky, B.,
and Orrenius, S.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
1259-1263 |
This article has been cited by other articles:
![]() |
J.-Y. Zheng, Y.-C. Tsai, P. Kadimcherla, R. Zhang, J. Shi, G. A. Oyler, and N. N. Boustany The C-Terminal Transmembrane Domain of Bcl-xL Mediates Changes in Mitochondrial Morphology Biophys. J., January 1, 2008; 94(1): 286 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Kwong, M. S. Henning, A. A. Starkov, and G. Manfredi The mitochondrial respiratory chain is a modulator of apoptosis J. Cell Biol., December 17, 2007; 179(6): 1163 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F Rezende, L. F Stoppiglia, K. L A Souza, A. Negro, F. Langone, and A. C Boschero Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway J. Endocrinol., October 1, 2007; 195(1): 157 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Miraglia, S. Travaglione, S. Meschini, L. Falzano, P. Matarrese, M. G. Quaranta, M. Viora, C. Fiorentini, and A. Fabbri Cytotoxic Necrotizing Factor 1 Prevents Apoptosis via the Akt/I{kappa}B Kinase Pathway: Role of Nuclear Factor-{kappa}B and Bcl-2 Mol. Biol. Cell, July 1, 2007; 18(7): 2735 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lopez-Sanchez, J.-R. Rodriguez, and J. M. Frade Mitochondrial c-Jun NH2-Terminal Kinase Prevents the Accumulation of Reactive Oxygen Species and Reduces Necrotic Damage in Neural Tumor Cells that Lack Trophic Support Mol. Cancer Res., January 1, 2007; 5(1): 47 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calcabrini, J. M. Garcia-Martinez, L. Gonzalez, M. J. Tendero, M. T. A. Ortuno, P. Crateri, A. Lopez-Rivas, G. Arancia, P. Gonzalez-Porque, and J. Martin-Perez Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate Carcinogenesis, August 1, 2006; 27(8): 1699 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Feldkamp, A. Kribben, N. F. Roeser, R. A. Senter, and J. M. Weinberg Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation Am J Physiol Renal Physiol, February 1, 2006; 290(2): F465 - F477. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Feldkamp, A. Kribben, and J. M. Weinberg F1FO-ATPase Activity and ATP Dependence of Mitochondrial Energization in Proximal Tubules after Hypoxia/Reoxygenation J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1742 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Feldkamp, A. Kribben, and J. M. Weinberg Assessment of mitochondrial membrane potential in proximal tubules after hypoxia-reoxygenation Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1092 - F1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Boustany, Y.-C. Tsai, B. Pfister, W. M. Joiner, G. A. Oyler, and N. V. Thakor BCL-xL-Dependent Light Scattering by Apoptotic Cells Biophys. J., December 1, 2004; 87(6): 4163 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Koshkin, G. Bikopoulos, C. B. Chan, and M. B. Wheeler The Characterization of Mitochondrial Permeability Transition in Clonal Pancreatic {beta}-Cells: MULTIPLE MODES AND REGULATION J. Biol. Chem., October 1, 2004; 279(40): 41368 - 41376. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Cancherini, L. G. Trabuco, N. A. Reboucas, and A. J. Kowaltowski ATP-sensitive K+ channels in renal mitochondria Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1291 - F1296. [Abstract] [Full Text] |
||||
![]() |
M. M. da Silva, A. Sartori, E. Belisle, and A. J. Kowaltowski Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H154 - H162. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||